New York-based WeWork said it will receive $3 billion in funding, in yet another investment from its already biggest financier Softbank Group Corp. Earlier in August, Softbank had injected $1 billion into WeWork in the form of a convertible note.
The latest round of financing comes in the form of a warrant, which allows Softbank to buy shares of WeWork at $110 or above before September 2019, depending on whether the company is acquired or publically listed. According to WeWork, the deal values the company at $42 billion.
According to Financial Times, the first tranche of $1.5 billion will be handed over on January 15, 2019, while the rest will be given three months later.
Though WeWork is primarily a provider of shared workspaces for technology startups, a third of its revenue comes from its enterprise products made for corporate clients.
Softbank’s Vision Fund had last year invested $4.4 billion in the company, making the Japanese multinational holding conglomerate its biggest backer. Softbank also holds two board seats in WeWork.
Since April, WeWork has been publically announcing its quarterly results, though it is still a privately held company. Over the past three quarters, the company has reported losses worth $1.22 billion on a revenue of $1.25 billion. According to company filings, last year it lost $933 million, despite reporting a top line of $886 million.
Though the company is yet to turn any profits, Softbank seems highly optimistic about it. If WeWork does, start turning in profits, Softbank would become the biggest beneficiary.
Get access to timely and accurate verbatim transcripts that are published within hours of the event
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments